EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy

Peng Xia, Chengming Qu, Xiaolong Xu, Ming Tian, Zhifen Li, Jingbo Ma, Rui Hou, Han Li, Felix Rückert, Tianyu Zhong, Liang Zhao, Yufeng Yuan und 2 weitere

Journal of Extracellular Vesicles · 2025-04 · 14 (4)

DOI: 10.1002/jev2.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 16.04.2025. Verfasst von Peng Xia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, Clinical Medicine Research Center for Minimally Invasive Procedu…. Hauptthemen laut MEDLINE: Immunotherapy, Photosensitizing Agents, Single-Domain Antibodies, Bacterial Outer Membrane. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, The Key Special Project of Strategic Science and Technology Innovation Cooperation from National Key R&D Program (2023YFE0204500).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial outer membrane vesicles (OMVs) are promising as antitumour agents, but their clinical application is limited by toxicity concerns and unclear mechanisms. We engineered OMVs with cadherin 17 (CDH17) tumour‐targeting nanobodies, enhancing tumour selectivity and efficacy while reducing adverse effects. These engineered OMVs function as natural stimulator of interferon genes (STING) agonists, activating the cyclic GMP‐AMP synthase (cGAS)‐STING pathway in cancer cells and tumour‐associated macrophages (TAMs). Loading engineered OMVs with photoimmunotherapy photosensitisers further enhanced tumour inhibition and STING activation in TAMs. Combining nanobody‐engineered OMV‐mediated photoimmunotherapy with CD47 blockade effectively suppressed primary and metastatic tumours, establishing sustained antitumour immune memory. This study demonstrates the potential of nanobody‐engineered OMVs as STING agonists and provides insights into novel OMV‐based immunotherapeutic strategies harnessing the innate immune system against cancer. Our findings open new avenues for OMV applications in tumour immunotherapy, offering a promising approach to overcome current limitations in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyPhotosensitizing AgentsSingle-Domain AntibodiesBacterial Outer MembraneExtracellular VesiclesNeoplasmsAnimalsMiceHumansCell Line, TumorMembrane ProteinsFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

CDH17STING pathwaybacterial outer membrane vesiclenanobodyphotoimmunotherapytumour‐associated macrophages

Substanzen

Photosensitizing AgentsSingle-Domain AntibodiesMembrane Proteins

Autor:innen und Institutionen

  • Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province, Wuhan Uni…
  • Department of Critical Care Medicine, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Centre for Geriatrics, Department of Nuclear Medicine, Shenzhen People's Hospital (The First…
  • Department of Chemistry, The University of Chicago, Chicago, Illinois, USA.
  • School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong, Shanxi Province, P. R. China.
  • Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.
  • Department of Visceral Surgery, Diakonissen Hospital, Speyer, Germany.

ORCID-Profile: Zhijie Li

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • The Key Special Project of Strategic Science and Technology Innovation Cooperation from National Key R&D Program (2023YFE0204500)
  • The China National Postdoctoral Program for Innovative Talents
  • China Postdoctoral Science Foundation
  • The Fundamental Research Funds for the Central Universities
  • The Hubei Natural Science Foundation
  • The Hubei Postdoctoral Science Foundation

Zitieren

APA

Xia, P., Qu, C., Xu, X., Tian, M., Li, Z., Ma, J., Hou, R., Li, H., Rückert, F., Zhong, T., Zhao, L., Yuan, Y., Wang, J., & Li, Z. (2025). Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy. Journal of Extracellular Vesicles, 14(4). https://doi.org/10.1002/jev2.70069

Vancouver

Xia P, Qu C, Xu X, Tian M, Li Z, Ma J, et al. Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy. Journal of Extracellular Vesicles. 2025;14(4). doi:10.1002/jev2.70069

BibTeX
@article{Xia2025,
  author = {Xia, Peng and Qu, Chengming and Xu, Xiaolong and Tian, Ming and Li, Zhifen and Ma, Jingbo and Hou, Rui and Li, Han and Rückert, Felix and Zhong, Tianyu and Zhao, Liang and Yuan, Yufeng and Wang, Jigang and Li, Zhijie},
  title = {Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  volume = {14},
  number = {4},
  doi = {10.1002/jev2.70069}
}
Kostenlos starten →